W. Kortmann

465 total citations
6 papers, 66 citations indexed

About

W. Kortmann is a scholar working on Endocrinology, Diabetes and Metabolism, Rehabilitation and Epidemiology. According to data from OpenAlex, W. Kortmann has authored 6 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Rehabilitation and 2 papers in Epidemiology. Recurrent topics in W. Kortmann's work include Diabetic Foot Ulcer Assessment and Management (3 papers), Wound Healing and Treatments (2 papers) and Urinary Tract Infections Management (1 paper). W. Kortmann is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (3 papers), Wound Healing and Treatments (2 papers) and Urinary Tract Infections Management (1 paper). W. Kortmann collaborates with scholars based in Netherlands, Canada and United States. W. Kortmann's co-authors include Michiel A. van Agtmael, Judi van Diessen, Prabath W.B. Nanayakkara, Jean-Paul P.M. de Vries, Eline Huizing, Çağdaş Ünlü, Michiel A. Schreve, Max Nieuwdorp, Edgar J.G. Peters and Elske Sieswerda and has published in prestigious journals such as Clinical Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases and Trials.

In The Last Decade

W. Kortmann

5 papers receiving 62 citations

Peers

Countries citing papers authored by W. Kortmann

Since Specialization

Citations

This map shows the geographic impact of W. Kortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Kortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Kortmann more than expected).

Fields of papers citing papers by W. Kortmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Kortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Kortmann. The network helps show where W. Kortmann may publish in the future.

Co-authorship network of co-authors of W. Kortmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Kortmann. A scholar is included among the top collaborators of W. Kortmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Kortmann. W. Kortmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Bone Biopsy not Superior to Ulcer Bed Biopsy–guided Antibacterial Therapy on Remission of Diabetic Foot Osteomyelitis: A Randomized Controlled Trial 2025 ·Clinical Infectious Diseases ·(unknown), (unknown), (unknown), Mehtab Ahmad, Annet M. Bosch, (unknown), Vincent de Groot, Jarne M. van Hattem, Martin den Heijer, W. Kortmann, Max Nieuwdorp, Edgar J.G. Peters	0
2	Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial 2021 ·Trials ·(unknown), (unknown), (unknown), Martin den Heijer, Vincent de Groot, Max Nieuwdorp, W. Kortmann, Elske Sieswerda, Edgar J.G. Peters	10
3	The effect of a multidisciplinary outpatient team approach on outcomes in diabetic foot care: a single center study 2020 ·The Journal of Cardiovascular Surgery ·Eline Huizing, Michiel A. Schreve, W. Kortmann, (unknown), Jean-Paul P.M. de Vries, Çağdaş Ünlü	11
4	Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·James Cohen Stuart, (unknown), W. Kortmann, (unknown), (unknown), Jelle Scharringa, Ad C. Fluit, Miquel B. Ekkelenkamp	11
5	Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients. 2015 ·PubMed ·Joop E. Arends, Jan T. M. van der Meer, Dirk Posthouwer, W. Kortmann, Kees Brinkman, Sander van Assen, Colette Smit, Marc van der Valk, Marchina van der Ende, Janke Schinkel, Peter Reiss, Clemens Richter, Andy I. M. Hoepelman, (unknown), (unknown)	3
6	5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. 2008 ·PubMed ·W. Kortmann, Michiel A. van Agtmael, Judi van Diessen, (unknown), (unknown), Prabath W.B. Nanayakkara	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact